FDA approves third COVID-19 antibody treatment for emergency use

0

FDA approves third COVID-19 antibody treatment for emergency use

A third antibody treatment designed to keep high-risk COVID-19 patients from being hospitalized was approved for emergency use by the U.S. Food and Drug Administration on Wednesday.

Comments are closed.

Tdap vaccination tied to lower dementia risk in older adults
28 May 2021
Providing more low-value care doesn’t lead to higher patient experience ratings
28 May 2021